This should become a major issue in political campaigns. People have been complaining about the discrepancy in what we pay for years. Practically everyone is effected.
The same game. A patient pays $250 and the rest will pay US taxpayer after Big Pharma and Insurance companies will at lease double their profit margins.
One element of Clinton’s plan is largely symbolic: the proposed shortening of the statutory exclusivity period for biologics from 12 years to 7 years. Such a change wouldn’t have much practical effect because most biologics have at least 12 years of US patent protection when they are launched in the US market.